The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hunter, R. L.
Right arrow Articles by Lal, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hunter, R. L.
Right arrow Articles by Lal, A. A.

The Journal of Immunology, Vol 154, Issue 4 1762-1769, Copyright © 1995 by American Association of Immunologists

ARTICLES

Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants

RL Hunter, MR Kidd, MR Olsen, PS Patterson and AA Lal
Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322.

We previously reported that protection of mice from nonlethal Plasmodium yoelii malaria by immunization with whole killed blood-stage parasites was dependent on the adjuvant and that adjuvants influenced both the specificity and isotype of Ab. Additional studies with the most effective formulations were undertaken to better define the protective responses and 100% protection from lethal P. yoelii malaria was produced by three immunizations with Ag in copolymer P1004 and detoxified RaLPS as adjuvants and 83% protection was induced by a single immunization. The protection lasted for 9 mo and was associated with an anamnestic rise in Ab titer of the IgG2a isotype during the challenge infection. Passive immunization with Ab from animals that had been immunized and challenged transferred sterile immunity. Splenectomy reduced, but did not abolish, protection. These data suggest that the effective Ab is directed against labile epitopes on the surface of blood-stage parasites. The vaccines primed animals for production of such Ab, but its synthesis was efficiently induced only by challenge with live organisms.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
P. M. Petritus and J. M. Burns Jr.
Suppression of Lethal Plasmodium yoelii Malaria following Protective Immunization Requires Antibody-, IL-4-, and IFN-{gamma}-Dependent Responses Induced by Vaccination and/or Challenge Infection
J. Immunol., January 1, 2008; 180(1): 444 - 453.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. Yang, W. E. Collins, J. S. Sullivan, D. C. Kaslow, L. Xiao, and A. A. Lal
Partial Protection against Plasmodium vivax Blood-Stage Infection in Saimiri Monkeys by Immunization with a Recombinant C-Terminal Fragment of Merozoite Surface Protein 1 in Block Copolymer Adjuvant
Infect. Immun., January 1, 1999; 67(1): 342 - 349.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
V. M. Jennings, A. A. Lal, and R. L. Hunter
Evidence for Multiple Pathologic and Protective Mechanisms of Murine Cerebral Malaria
Infect. Immun., December 1, 1998; 66(12): 5972 - 5979.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.